Concepedia

Cory R. Heilmann

CR

13

Publications

1.6K

Citations

12

H-Index

1988

Active since

Affiliations

Eli Lilly (United States)(Current)

University of North Carolina at Chapel Hill

Dallas Diabetes Research Center

Tris Pharma (United States)

Masonic Medical Research Laboratory

Cory R. Heilmann is an author at Eli Lilly (United States) specializing in medicine, physiology, and diabetes.

Top concepts

Publications per year

1988–2017

13

Publications

13

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

John B. Buse, Michael A. Nauck, Thomas Först et al. · The Lancet · 2012 · 559 citations

, , +5

Use of Twice-Daily Exenatide in Basal Insulin–Treated Patients With Type 2 Diabetes

John B. Buse, Richard M. Bergenstal, Leonard C. Glass et al. · Annals of Internal Medicine · 2011 · 503 citations

Transmural heterogeneity of calcium activity and mechanical function in the canine left ventricle

Jonathan M. Cordeiro, Lindsey A. Greene, Cory R. Heilmann et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2004 · 197 citations

, , +22

Effects of Sodium Channel Block with Mexiletine to Reverse Action Potential Prolongation in In Vitro Models of the Long QT Syndrome

Serge Sicouri, Daniel Antzelevitch, Cory R. Heilmann et al. · Journal of Cardiovascular Electrophysiology · 1997 · 75 citations

Baseline Factors Associated With Glycemic Control and Weight Loss When Exenatide Twice Daily Is Added to Optimized Insulin Glargine in Patients With Type 2 Diabetes

Julio Rosenstock, Sylvia Shenouda, Richard M. Bergenstal et al. · Diabetes Care · 2012 · 67 citations · Full text

Rows per page

1–5 of 13